Citius Pharmaceuticals, Inc. Class of Warrant or Right, Outstanding
Citius Pharmaceuticals, Inc. (CTXR) had Class of Warrant or Right, Outstanding of 17.62 million shares as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-08-12
- 2025-06-30: Class of Warrant or Right, Outstanding 17.62M shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 4.25M shares.
- 2024-12-31: Class of Warrant or Right, Outstanding 3.46M shares.
- 2024-09-30: Class of Warrant or Right, Outstanding 2.95M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2025-06-30 | 17.62M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 4.25M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 3.46M shares 10-Q · filed 2025-02-14 |
| 2024-09-30 | 2.95M shares 10-K · filed 2024-12-27 |
| 2024-06-30 | 73.63M shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 50.70M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 50.70M shares 10-Q · filed 2024-02-14 |
| 2018-09-30 | 8.40M shares 10-K · filed 2018-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |